Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

131.09
Delayed Data
As of May 29
 +2.59 / +2.02%
Today’s Change
51.93
Today|||52-Week Range
133.96
+35.14%
Year-to-Date

Today’s Trading

Previous close128.50
Today’s open128.98
Day’s range128.40 - 133.96
Volume3,431,344
Average volume (3 months)765,756
Market cap$11.0B
Dividend yield--
Data as of 3:59pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+38.24%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book10.81

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.88-1.25%
ISISIsis Pharmaceuticals...+0.61+0.91%
ICLRICON PLC-1.04-1.58%
DYAXDyax Corp-0.12-0.45%
Data as of 4:02pm ET, 05/29/2015

Financials

Next reporting dateAugust 3, 2015
EPS forecast (this quarter)-$0.74
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers